Multiple Myeloma, Diagnostic Panel-2 near me in Nagpur

Multiple myeloma (MM) is a cancer that affects plasma cells, a type of white blood cell responsible for producing antibodies. In MM, cancerous plasma cells accumulate in the bone marrow and produce abnormal proteins called M proteins. These proteins can interfere with normal blood cell function and cause symptoms like bone pain, fatigue, weakness, weight loss, and frequent infections.

The Multiple Myeloma, Diagnostic Panel-2 includes Serum Protein Electrophoresis (SPEP), Immunofixation Electrophoresis (SIFE), Beta-2 Microglobulin, and Free Light Chain assay (Kappa/Lambda). SPEP measures the overall levels of proteins in the blood, while SIFE identifies the specific type of abnormal proteins. The Free Light Chain assay quantifies light chains produced by myeloma cells, and Beta-2 Microglobulin is a marker of disease burden and prognosis.

By analyzing all these parameters together, this panel provides a detailed insight about the disease, helping doctors diagnose multiple myeloma, evaluate disease stage, monitor treatment response, and plan personalized therapies for optimal outcomes.

Doctors may recommend this panel for individuals with symptoms suggestive of multiple myeloma, abnormal blood test results, or those already diagnosed with the disease to monitor progression and response to treatment.

For this test, it is important to submit the clinical history, histopathology report, previous test results, and a doctor’s prescription at the time of sample collection. The Tata 1mg consolidated Test Requisition Form (TRF) must also be duly filled and submitted.

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.